Dual site proteomic analyses reveal potential drug targets for cardiovascular disease
Christopher Aldous Oldnall, Koy Chong Ng Kee Kwong, Jimi C. Wills, Anne Richmond, Tim W. Regan, Sara Clohisey, Archie I Campbell, John Kenneth Baillie, Alex von Kriegsheim, Chris Haley, Ava Khamseh, Sjoerd Viktor Beentjes, Andrew D. Bretherick
This paper uses Mendelian randomisation to identify potential drug targets for cardiovascular disease by analysing protein levels in plasma and PBMCs from large cohorts.
medRxiv · Jul 27, 2024 · PreprintGenetic & Genomic Medicine